Editor's note: Every morning, James Altucher presents the most timely, topical posts from the Web's best business blogs.
Is the FDA
and others hit the
list for this morning.
Jeff Miller over at A Dash of Insight provides some
. By the way, Jeff is one of the best new columnists over at
, and I can't recommend enough reading his work.
and replaced by
. What will this mean for
now with Microsoft
fascinating perspective from Crossing Wall Street
on what's really been going on with inflation since World War II.
trading for less than 10 times cash flows.
Donaldson Capital is
Bank of America
, and I agree with him.
Hilary Kramer insists that
The most important economic number has been ignored in all the fuss. I can't emphasize enough
how important increases in productivity are
Modern Graham does its
Here it goes again: Now
Research In Motion
. Here's why.
At the time of publication, Altucher and/or his fund had no positions in any of the stocks mentioned, although positions may change at any time.
James Altucher is president of Stockpickr LLC, a wholly owned subsidiary of TheStreet.com and part of its network of Web properties, and a managing partner at Formula Capital, an alternative asset management firm that runs a fund of hedge funds. He is also a weekly columnist for
The Financial Times
and the author of
Trade Like a Hedge Fund
Trade Like Warren Buffett
. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback;
to send him an email.
TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.